Vaxcyte is a clinical-stage vaccine innovation company dedicated to creating high-fidelity vaccines designed to prevent and treat some of the world's most challenging bacterial diseases. By utilizing its proprietary cell-free protein synthesis platform, the company is advancing a diverse pipeline of complex, multi-valent vaccines targeting conditions such as pneumococcal disease, Group A Strep, and Shigella.
Driven by a mission to protect lives through scientific breakthrough, Vaxcyte fosters a culture defined by ambition, integrity, and empathy. The team is composed of passionate experts who are rethinking traditional approaches to vaccine science to address significant unmet medical needs. For professionals looking to make a lasting impact in the biotech sector, Vaxcyte offers a unique opportunity to work at the intersection of cutting-edge technology and global public health.